Core Viewpoint - The performance of Runfeng Co., Ltd. has significantly improved, necessitating a reassessment of the value of its formulation exports, with expected net profit attributable to shareholders projected at 1.03-1.17 billion yuan, representing a year-on-year increase of 129% to 160% [1] Financial Performance - The company anticipates a net profit of 140-280 million yuan for Q4 2025, reflecting a year-on-year growth of 9% to 119%, but a quarter-on-quarter decline of 62% to 25% [1] - The overall performance for 2025 is expected to show substantial improvement due to the gradual recovery of procurement demand and the bottoming out of product prices [1] Market Outlook - Looking ahead to 2026, the demand for pesticides and product prices are expected to improve further compared to 2025, particularly with seasonal orders likely to exceed expectations, driving accelerated recovery in market conditions [1] - As a leading domestic exporter of formulations, the company is continuously enhancing its global marketing network, which will strengthen its profitability as the ModelC business matures and its market share increases [1] Strategic Positioning - The company is well-positioned to expand into high-barrier, high-value markets such as North America and the European Union, which will contribute to sustained improvements in profitability [1] - The industry is experiencing a steady recovery in market conditions, with ongoing strategic planning and continuous improvement in operational quality [1]